BTC Health (ASX:BTC) Expands Distribution Partnership with Arna Pharma
Partnership Expansion
BTC Health has extended its partnership with Arna Pharma by converting the License and Distribution Agreement for Bronchitol and Aridol from a 10-year term to an indefinite license. BTC will earn royalties from sales of these products in Singapore and Malaysia and has been granted the first right of refusal for Arna Pharma’s new product pipeline.
Executive Comments
Dr Richard Treagus, Executive Chairman of BTC Health, said, “This expanded partnership agreement with Arna Pharma combines the established strengths of Arna Pharma’s product development and manufacturing capabilities and BTC Pharma’s distribution and marketing expertise. We are very excited by the potential of bringing novel pharmaceutical products to Australian patients.”
Motley Fool contributor Lauren Surplice has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.